Robert Marchesani

Robert Marchesani

MBA / Board Member

Mr Robert Marchesani is president of Proventus Consulting LLC and an adjunct faculty member and executive mentor at Butler University, Lacy School of Business in Indianapolis, Indiana. At Proventus, he serves as a consultant to oncology companies to incorporate prescriber, patient and payer insights throughout drug development and commercialization. Prior to joining Proventus, Mr. Marchesani spent more than 25 years at Eli Lilly and Company where he led the global branding, marketing and launch of a number of cancer therapeutics including, ALIMTA® (pemetrexed), Gemzar® (gemcitabine) and Verzenio™ (abemaciclib). Mr. Marchesani received his Bachelor of Arts degree in journalism and public relations from Indiana University of Pennsylvania and Masters of Business Administration with a concentration in marketing from the University of Indianapolis.

Position: Board Member

Elected: 2019 (2018 as an advisor)

Year of birth: 1961

Holdings: 5 000 shares*

Independent in relation to the company and its management: Yes

Independent in relation to larger shareholders: Yes

*Own or related natural or legal person holding shares and other financial instruments in the company. Holdings as of March 31, 2022.